ImmunityBio
IBRX
IBRX
104 hedge funds and large institutions have $155M invested in ImmunityBio in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.31% more ownership
Funds ownership: 9.43% → 10.75% (+1.3%)
59% less call options, than puts
Call options by funds: $9.93M | Put options by funds: $24.1M
Holders
104
Holding in Top 10
–
Calls
$9.93M
Puts
$24.1M
Top Buyers
| 1 | +$16M | |
| 2 | +$4.58M | |
| 3 | +$4.12M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.15M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.09M |
Top Sellers
| 1 | -$4.28M | |
| 2 | -$2.98M | |
| 3 | -$2.12M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.35M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$873K |